5-HT1A receptor-effector system responsivity in panic disorder

Psychopharmacology

Volumn 106, Issue 1, 1992, Pages 111-117

  Lesch, K P ^a   Wiesmann, M ^a   Hoh, A ^a   Muller T ^a   Disselkamp Tietze, J ^a   Osterheider, M ^a   Schulte, H M ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

5 HT1A receptor; ACTH; Anxiety; Cortisol; Hypothermia; Ipsapirone; Panic disorder

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; IPSAPIRONE; PLACEBO; SEROTONIN 1A RECEPTOR; ANTI ANXIETY AGENTS; ANXIOLYTIC AGENT; PYRIMIDINE DERIVATIVE; SEROTONIN RECEPTOR;

ADULT; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTHERMIA; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; THERMOREGULATION;

ADULT; ANTI-ANXIETY AGENTS; BODY TEMPERATURE REGULATION; CORTICOTROPIN; DOUBLE-BLIND METHOD; FEMALE; HUMAN; HYDROCORTISONE; MALE; NEUROSECRETORY SYSTEMS; PANIC DISORDER; PYRIMIDINES; RADIOIMMUNOASSAY; RECEPTORS, SEROTONIN;

EID: 0026610459     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02253597     Document Type: Article

References (45)

1. The effect of gepirone on neuroendocrine function and temperature in humans
2. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors
3. l-Tryptophan and prolactin release: evidence for 5-HT1 and 5-HT2 receptors
4. Serotonin function in anxiety: II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects
5. Animal models of anxiety: the effects of compounds that modify 5-HT neurotransmission
6. Effect of serotonin and noradrenaline uptake inhibitor in panic disorder: a double-blind comparative study with fluvoxamine and maprotiline
7. Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluoxetine
8. Measurement of lactate-induced panic and anxiety
9. Brain 5-HT1A receptors and anxiety
10. Interaction of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis
11. G proteins: transduction of receptor-generated signals
12. Serotonin receptors: clinical implications
13. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di- n-propylamino)tetralin (8-OH-DPAT)
14. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat
15. An open trial of fluoxetine in the treatment of panic attacks
16. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat
17. 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain
18. A rating scale for depression
19. Molecular biology of 5-HT receptors
20. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings
21. Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity
22. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder
23. Behavioral indications for serotonin receptor hypersensitivity in panic disorder
24. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors
25. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action
26. Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation
27. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone
28. Modification of 8-OH-DPAT-induced hypothermia after acute or subchronic ritanserin treatment
29. Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans
30. The pharmacology of the hypothermic response to 5-HT1A receptor activation in humans
31. Corticotropin and cortisol secretion following central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and β-adrenoceptor antagonists
32. 5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder: comparison of patients and controls
33. Regulation of G proteins by chronic antidepressant drug treatment in rat brain: tricyclics but not dorgyline increase G0α subunits
34. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists
35. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems
36. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers
37. Chronic elektroconvulsive shock and desipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes
38. Platelet binding studies in panic disorder
39. Cortisol and growth hormone response to the 5-HT1A agonist gepirone in depressed patients
40. 5-HT1A receptor-related anxiolytics
41. Platelet [3H]imipramine binding in patients with panic disorder
42. Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls